Rangering i aksjer
#36613
Arix Bioscience plc operates as a venture capital firm, focusing its... Arix Bioscience plc operates as a venture capital firm, focusing its investments across the entire lifecycle of companies, from nascent seed-stage ventures and preclinical or clinical asset development to early, mid, and late-stage growth capital rounds, encompassing both private and public equity. The firm's investment mandate is global, targeting the biotechnology sector and seeking out entities involved in groundbreaking therapeutics, cutting-edge technologies, and broader medical innovations spanning healthcare and life sciences. Employing an evergreen funding model, Arix Bioscience predominantly deploys capital directly from its own balance sheet. It generally prefers to secure a board position within its portfolio companies and strategically exits investments once the peak value has been realized. Established in 2015 and headquartered in London, United Kingdom, the company was previously known as Perceptive Bioscience Investments Limited.
Aksjekurs
$1.93
Sist synkronisert: 2024-02-09
Handel Arix Bioscience plc (ARIX)
Pris ARIX pris med markedsverdi på B
Markedsverdi av Arix Bioscience plc(ARIX)
Markedsverdi: $2.50M
Per August 2026 har Arix Bioscience plc en markedsverdi på $2.50M. Dette gjør Arix Bioscience plc til det 36613th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Arix Bioscience plc fra 2017 til 2026
ARIX sammenlignet med topp 5 mest populære stocks
| Pris på ARIX |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.452T
|
+218,060,416.09%
|
|
|
|
|
$4.490T
|
+179,589,017.57%
|
|
|
|
|
$4.162T
|
+166,485,344.45%
|
|
|
|
|
$3.676T
|
+147,044,026.68%
|
|
|
|
|
$2.833T
|
+113,314,229.56%
|
